CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.
May 26th 2023
From YouTuber Hank Green announcing his lymphoma diagnosis, to Jeff Bridges, Martina Navratilova and Leanne Hainsby giving updates on their cancer, here’s what’s happening in the oncology space this week.
May 24th 2023
“Nobody’s going to fight for your life the way you’re going to fight for your life,” Hodgkin’s lymphoma survivor, Paula Ngon, told CURE®.
May 19th 2023
The FDA approval of Epkinly also includes a subset of patients with indolent lymphoma-related DLBCL and those with high-grade B-cell lymphoma after two or more systemic therapies.
May 18th 2023
Cryopreserved stem cells led to a higher rate of relapse in patients with blood cancer, though there was no difference in survival, research showed.
April 21st 2023
From ‘Pokémon’ actor James Carter Cathcart stepping away from the show to undergo cancer treatment to Ahmad Jamal and Otis Redding III dying of cancer, here’s what’s happening in the oncology space this week.
April 20th 2023
Cancer-related can be consuming, so my sister and I make sure to celebrate the little victories along the way.
April 19th 2023
The Food and Drug Administration approved Polivy plus Rituxan, cyclophosphamide, doxorubicin and prednisone for patients with previously untreated diffuse large B-cell lymphoma — marking the first new regimen in nearly two decades for this patient population.
April 18th 2023
One patient was able to access a therapy for follicular lymphoma before it was approved by the FDA, which allowed him to help future patients through his experience.
April 17th 2023
Omisirge is an umbilical cord blood-based therapy that may prevent infection in patients with blood cancer undergoing stem cell transplant.
April 5th 2023
I learned that self-advocacy is not about proving an oncology wrong or deciding that one drug is better than the other. It’s about speaking up for what you think is right.
March 23rd 2023
Choosing to get a mastectomy was a difficult decision to make, but then the pathology results came back indicating a second cancer.
March 14th 2023
Cancer-related decisions put strain on relationships between myself and family members.
March 6th 2023
This updated administration of Udenyca allows patients to receive this treatment in the office or at home.
February 27th 2023
Cancer survivors who are experiencing side effects from treatment, such as chronic fatigue, may benefit from a healthier diet.
February 24th 2023
From comedian Chris Tucker teaming up with a nonprofit to educate Black men on their prostate cancer risk to Leeane Hainby and Rep. Jamie Raskin providing updates on their cancer treatment, here’s what’s happening in the cancer space this week.
February 21st 2023
After receiving supportive care during her college cancer journey, this survivor now works to guide other patients through their treatments.
February 20th 2023
Patients with cancer should keep a healthy heart during cancer treatment by exercising regularly and eating healthy, an expert emphasized.
February 15th 2023
I was optimistic about my lymphoma diagnosis and new treatment plan when a lump was found after I underwent a mammogram.
January 31st 2023
After being diagnosed with cancer, I’m nervous to plan for my future, and can’t say I’m in remission without knocking on wood.
January 23rd 2023
I exercised and ate healthy, yet still received a cancer diagnosis, leaving me wondering, “why me?”
January 20th 2023
From Tennis star Chris Evert’s cancer-free status to Duran Duran’s Andy Taylor talking about his prostate cancer, here’s what’s happening in the oncology space this week.
January 16th 2023
Patients with blood cancer may develop serious infections after transplants, but a T-cell therapy may improve symptoms and side effects.
December 27th 2022
There were some monumental FDA approvals in the cancer space during 2022 — here’s a roundup of our most-read agency decisions of the year.
December 26th 2022
Data demonstrate that iberdomide alone or in combination with other treatments may be a promising option for patients with relapsed/refractory lymphoma.
December 23rd 2022
Patients with relapsed/refractory follicular lymphoma — a group that traditionally has limited treatment options — now have a new bispecific antibody available.
December 8th 2022
Robert Atteberry never gave up, even after three cancer diagnoses, and has found a motivation and passion for competing in triathlons during survivorship.
December 7th 2022
Years after I went through mesothelioma, my husband was diagnosed with cancer, causing a reversal in the patient-caregiver roles.
November 23rd 2022
The Food and Drug Administration granted a priority review to epcoritamab for certain patients with large B-cell lymphoma, an aggressive type of blood cancer.
November 10th 2022
The Food and Drug Administration approved Adcetris plus chemotherapy for pediatric patients with classical high-risk Hodgkin lymphoma.